SCHEMBL31359094

SCHEMBL31359094

C[C@@H](NC(=O)Cn1c(=O)[nH]c2cccc(C#N)c2c1=O)c1ncc(C#N)cn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ELANE P08246 5/20 0.38
▸ ITGB1 P05556 2/20 0.37
▸ ITGAV P06756 2/20 0.37
▸ ITGA5 P08648 2/20 0.37
▸ ITGA4 P13612 2/20 0.37
▸ GPR139 Q6DWJ6 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ GRIN1 Q05586 2/20 0.35
▸ GRIN2B Q13224 2/20 0.35
▸ HPGD P15428 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ USP1 O94782 1/20 0.34
▸ MAPK1 P28482 1/20 0.33
▸ B3GNT2 Q9NY97 1/20 0.33
▸ PIK3CD O00329 1/20 0.32
▸ PIK3R1 P27986 1/20 0.32
▸ PIK3CG P48736 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31359073 1.00 ELANE (0.38) ELANEITGB1ITGAVITGA5ITGA4
SCHEMBL31359118 0.90 FEN1 (0.40) ELANEITGB1ITGAVITGA5ITGA4
SCHEMBL31358983 0.90 FEN1 (0.40) ELANEITGB1ITGAVITGA5ITGA4
SCHEMBL31358993 0.86 ELANE (0.37) ELANEITGB1ITGAVITGA5ITGA4
SCHEMBL31359077 0.86 ELANE (0.37) ELANEITGB1ITGAVITGA5ITGA4
SCHEMBL31358997 0.85 GPR139 (0.35) ELANEITGB1ITGAVITGA5ITGA4
SCHEMBL31359006 0.85 GPR139 (0.35) ELANEITGB1ITGAVITGA5ITGA4
SCHEMBL31359059 0.85 GPR139 (0.37) ELANEITGB1ITGAVITGA5ITGA4
SCHEMBL31359113 0.85 GPR139 (0.37) ELANEITGB1ITGAVITGA5ITGA4
SCHEMBL31359064 0.80 CNR2 (0.40) GPR139GRIN1GRIN2BPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12559464-B2 Quinazolinone dione compounds and uses thereof EDGEWISE THERAPEUTICS, INC. (US) 2026-02-24 — — US disclosed
US-20250026726-A1 QUINAZOLINONE DIONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. 2025-01-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250026726-A1 QUINAZOLINONE DIONE COMPOUNDS AND USES THEREOF TNNI3, TNNT2, MYLK2 ELANE 3336/4885ITGB1 4506/4885ITGAV 4631/4885
US-12559464-B2 Quinazolinone dione compounds and uses thereof TNNI3, TNNT2, TNNC1 ELANE 3301/4885ITGB1 1810/4885ITGAV 4526/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback